Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec 22;12:1081089. doi: 10.3389/fonc.2022.1081089

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Guo, Qiu, Pan and Lin

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Predictive effectiveness evaluation of the cuproptosis-related lncRNA signature. (A, B) The distribution and median risk score in training group (A) and validation group (B); the cutoff value of high- and low- risk sets was set as the median risk score of training cohort. (C, D) Kaplan–Meier survival curves for training (C) and validation (D) groups suggested that the OS of the high-risk sets was lower than that of the low-risk sets (p = 2.161E−08 and p = 2.059E−03). (E, F) ROC curve analysis for the accuracy of the risk model to forecast clinical outcomes of patients with BC at 5, 7, and 10 years in training (E) and validation (F) groups. (G, H) The distributions of survival time status in training (G) and validation (H) sets. lncRNA, long non-coding RNA; OS, overall survival; ROC, receiver operating characteristic; BC, breast cancer.